A Farnesyl-Protein Transferase Inhibitor Induces p21 Expression and G1 Block in p53 Wild Type Tumor Cells

This publication has 34 references indexed in Scilit:

• Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo
  Journal of Biological Chemistry, 1997
• THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
  Annual Review of Pharmacology and Toxicology, 1997
• Cholesterol Metabolism and Tumor Cell Proliferation
  Published by Springer Nature ,1997
• PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
  Annual Review of Biochemistry, 1996
• Farnesyltransferase inhibitors and anti-Ras therapy
  Breast Cancer Research and Treatment, 1996
• Disruption of Oncogenic K-Ras4B Processing and Signaling by a Potent Geranylgeranyltransferase I Inhibitor
  Published by Elsevier ,1995
• Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice
  Nature Medicine, 1995
• Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in Vitro
  Journal of Biological Chemistry, 1995
• Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.
  Proceedings of the National Academy of Sciences, 1994
• Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton.
  Molecular and Cellular Biology, 1994